Literature DB >> 12006575

The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins.

Vida Senkus Melvin1, Sarah C Roemer, Mair E A Churchill, Dean P Edwards.   

Abstract

Previously, we and others reported that the high mobility group proteins, HMGB-1/-2, enhance DNA binding in vitro and transactivation in situ by the steroid hormone subgroup of nuclear receptors but did not influence these functions of class II receptors. We show here that the DNA binding domain (DBD) is sufficient to account for the selective influence of HMGB-1/-2 on the steroid class of receptors. Furthermore, the use of chimeric DBDs reveals that this selectivity is dependent on the C-terminal extension (CTE), amino acid sequences adjacent to the zinc finger core DBD. HMGB-1/-2 interact directly with the DBDs of steroid but not class II receptors, and this interaction requires the CTE. This in vitro interaction correlates with a requirement of the CTE for maximal HMGB-1/-2 enhancement of DNA binding in vitro and transcriptional activation in cells. Finally, class II receptor DBDs have a much higher intrinsic affinity for DNA than steroid receptor DBDs, and this affinity difference is also dependent on the CTE. These results reveal the importance of the steroid receptor CTE for DNA binding affinity and functional response to HMGB-1/-2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006575     DOI: 10.1074/jbc.M110400200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors.

Authors:  Vincent J Hilser; E Brad Thompson
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Interactions of the crustacean nuclear receptors HR3 and E75 in the regulation of gene transcription.

Authors:  Bethany R Hannas; Ying H Wang; William S Baldwin; Yangchun Li; Andrew D Wallace; Gerald A LeBlanc
Journal:  Gen Comp Endocrinol       Date:  2010-03-24       Impact factor: 2.822

Review 3.  High mobility group protein 1: A collaborator in nucleosome dynamics and estrogen-responsive gene expression.

Authors:  William M Scovell
Journal:  World J Biol Chem       Date:  2016-05-26

4.  Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.

Authors:  Sarah C Roemer; Douglas C Donham; Lori Sherman; Vickie H Pon; Dean P Edwards; Mair E A Churchill
Journal:  Mol Endocrinol       Date:  2006-08-24

5.  A Structural Investigation into Oct4 Regulation by Orphan Nuclear Receptors, Germ Cell Nuclear Factor (GCNF), and Liver Receptor Homolog-1 (LRH-1).

Authors:  Emily R Weikum; Micheal L Tuntland; Michael N Murphy; Eric A Ortlund
Journal:  J Mol Biol       Date:  2016-10-27       Impact factor: 5.469

Review 6.  Structural and functional analysis of domains of the progesterone receptor.

Authors:  Krista K Hill; Sarah C Roemer; Mair E A Churchill; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-07-22       Impact factor: 4.102

7.  Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism.

Authors:  Suzanne E Wardell; Stanley C Kwok; Lori Sherman; Robert S Hodges; Dean P Edwards
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

8.  Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.

Authors:  Mi Young Kim; Eileen M Woo; Yee Ting Esther Chong; Daria R Homenko; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2006-02-23

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

10.  A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.

Authors:  Krista K Hill; Sarah C Roemer; David N M Jones; Mair E A Churchill; Dean P Edwards
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.